recombinant zoster vaccine (CHO cell) (REC610)
/ Jiangsu Rec-Biotech
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
March 01, 2024
The Safety and Immunogenicity Study of the Recombinant Zoster Vaccine (CHO Cell)
(clinicaltrials.gov)
- P1 | N=48 | Completed | Sponsor: Jiangsu Rec-Biotechnology Co., Ltd. | Recruiting ➔ Completed | Trial completion date: Mar 2024 ➔ Dec 2023
Trial completion • Trial completion date • Herpes Zoster • Varicella Zoster
March 15, 2023
The Safety and Immunogenicity Study of the Recombinant Zoster Vaccine (CHO Cell)
(clinicaltrials.gov)
- P1 | N=48 | Recruiting | Sponsor: Jiangsu Rec-Biotechnology Co., Ltd.
New P1 trial • Herpes Zoster • Varicella Zoster • CD4 • IL2
1 to 2
Of
2
Go to page
1